Adverse events264

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 264

Type	Event	Organ system	Group	Affected	At risk
other	Headache	Nervous system disorders	Open-label Fondaparinux 2.5 mg	18	1,209
other	Headache	Nervous system disorders	OL Fondaparinux Background + Low Dose UFH During PCI	24	1,024
other	Headache	Nervous system disorders	OL Fondaparinux Background + Standard Dose UFH During PCI	28	1,002
other	Gastritis	Gastrointestinal disorders	Open-label Fondaparinux 2.5 mg	15	1,209
other	Gastritis	Gastrointestinal disorders	OL Fondaparinux Background + Low Dose UFH During PCI	0	1,024
other	Gastritis	Gastrointestinal disorders	OL Fondaparinux Background + Standard Dose UFH During PCI	2	1,002
other	Urinary tract infection	Infections and infestations	Open-label Fondaparinux 2.5 mg	15	1,209
other	Urinary tract infection	Infections and infestations	OL Fondaparinux Background + Low Dose UFH During PCI	5	1,024
other	Urinary tract infection	Infections and infestations	OL Fondaparinux Background + Standard Dose UFH During PCI	5	1,002
other	Asthenia	General disorders	Open-label Fondaparinux 2.5 mg	13	1,209
other	Asthenia	General disorders	OL Fondaparinux Background + Low Dose UFH During PCI	7	1,024
other	Asthenia	General disorders	OL Fondaparinux Background + Standard Dose UFH During PCI	3	1,002
other	Pyrexia	General disorders	Open-label Fondaparinux 2.5 mg	13	1,209
other	Pyrexia	General disorders	OL Fondaparinux Background + Low Dose UFH During PCI	11	1,024
other	Pyrexia	General disorders	OL Fondaparinux Background + Standard Dose UFH During PCI	16	1,002
other	Post procedural discharge	Injury, poisoning and procedural complications	Open-label Fondaparinux 2.5 mg	11	1,209
other	Post procedural discharge	Injury, poisoning and procedural complications	OL Fondaparinux Background + Low Dose UFH During PCI	9	1,024
other	Post procedural discharge	Injury, poisoning and procedural complications	OL Fondaparinux Background + Standard Dose UFH During PCI	15	1,002
other	Constipation	Gastrointestinal disorders	Open-label Fondaparinux 2.5 mg	10	1,209
other	Constipation	Gastrointestinal disorders	OL Fondaparinux Background + Low Dose UFH During PCI	5	1,024

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00790907/events

API reference For AI assistants

Adverse events264

Sources 3

Read this list from software.